119
Participants
Start Date
November 30, 2013
Primary Completion Date
June 30, 2015
Study Completion Date
August 31, 2015
RHB-105
"The intended dose is RHB-105 (12.5 mg rifabutin, 250 mg amoxicillin, and 10 mg omeprazole capsules) 4 capsules every eight hours, equivalent to a total daily dose of:~* Rifabutin 150 mg~* Amoxicillin 3000 mg~* Omeprazole 120 mg~Subjects will take study drug every 8 hours with food for 14 consecutive days."
Placebo
Subjects will take 4 placebo capsules every 8 hours with food for 14 days.
MGG Group Co. Chevy Chase Clinical Research, Chevy Chase
Peters Medical Research, High Point
Wake Research Associates, Raleigh
Columbus Regional Research Institute, Columbus
Jupiter Research, Inc., Jupiter
Investigative Clinical Research, Annapolis
Detroit Clinical Research Center, Farmington Hills
MedPharmics, Metairie
Office of Dr. Stephen Miller, MD, Las Vegas
Catalina Research Institute, Chino
Anaheim Clinical Trials, LLC, Anaheim
Anaheim Clinical Trials, Anaheim
RedHill Biopharma Limited
INDUSTRY